Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.

Item
http://www.wikidata.org/entity/Q33498657
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours.Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer.Combination metronomic oral topotecan and pazopanib: a pharmacokinetic study in patients with gynecological cancer.Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal functionOral topotecan: bioavailablity and effect of food co-administrationPopulation Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.Topotecan: a new topoisomerase I inhibiting antineoplastic agent.Chronic neuroblastoma.Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.Clinical pharmacology of camptothecins.
P2860

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.

Item
http://www.wikidata.org/entity/Q33498657
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@ast
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
type
label
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@ast
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
prefLabel
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@ast
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Phase I and pharmacologic stud ...... lt patients with solid tumors.
@en
P2093
P304
P31
P356
10.1200/JCO.1997.15.3.1087
P407
P433
P478
P577
P698